Anne-Laure Bulin

Dr. Anne-Laure Bulin

Synchrotron Radiation for Biomedicine, UA07 INSERM - Université Grenoble Alpes
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Theranostics
Verified
Journal Article
Open access
Srivalleesha MallidiSrivalleesha Mallidi
Srivalleesha Mallidi
SASriram Anbil
Sriram Anbil
Anne-Laure BulinAnne-Laure Bulin
Anne-Laure Bulin
GOGirgis Obaid
Girgis Obaid
MIMegumi Ichikawa
Megumi Ichikawa
THTayyaba Hasan
Tayyaba Hasan
Photodynamic therapy (PDT) is a photochemistry based treatment modality that involves the generation of cytotoxic species through the interactions of a photosensitizer molecule with light irradiation of an appropriate wavelength. PDT is an approved therapeutic modality for several cancers globally and in several cases has proved to be effective where traditional treatments have failed. The key parameters that determine PDT efficacy are 1. the photosensitizer (nature of the molecules, selectivity, and macroscopic and microscopic localization etc.), 2. light application (wavelength, fluence, fluence rate, irradiation regimes etc.) and 3. the microenvironment (vascularity, hypoxic regions, stromal tissue density, molecular heterogeneity etc.). Over the years, several groups aimed to monitor and manipulate the components of these critical parameters to improve the effectiveness of PDT treatments. However, PDT is still misconstrued to be a surface treatment primarily due to the limited depths of light penetration. In this review, we present the recent advances, strategies and perspectives in PDT approaches, particularly in cancer treatment, that focus on increasing the 'damage zone' beyond the reach of light in the body. This is enabled by a spectrum of approaches that range from innovative photosensitizer excitation strategies, increased specificity of phototoxicity, and biomodulatory approaches that amplify the biotherapeutic effects induced by photodynamic action. Along with the increasing depth of understanding of the underlying physical, chemical and physiological mechanisms, it is anticipated that with the convergence of these strategies, the clinical utility of PDT will be expanded to a powerful modality in the armamentarium for the management of cancer.

20 June 2016 in Nanoscale
Verified
Journal Article
Closed access
PDF file
GOGirgis Obaid
Girgis Obaid
Mans BroekgaardenMans Broekgaarden
Mans Broekgaarden
Anne-Laure BulinAnne-Laure Bulin
Anne-Laure Bulin
HHHuang-Chiao Huang
Huang-Chiao Huang
JKJerrin Kuriakose
Jerrin Kuriakose
THTayyaba Hasan
Tayyaba Hasan
As clinical nanomedicine has emerged over the past two decades, phototherapeutic advancements using nanotechnology have also evolved and impacted disease management.

19 September 2013 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
Anne-Laure BulinAnne-Laure Bulin
Anne-Laure Bulin
CTCharles Truillet
Charles Truillet
RCRima Chouikrat
Rima Chouikrat
FLFrançois Lux
François Lux
CFCéline Frochot
Céline Frochot
CDChristophe Dujardin
Christophe Dujardin

23 February 2015 in Nanoscale
Verified
Journal Article
Closed access
PDF file
Anne-Laure BulinAnne-Laure Bulin
Anne-Laure Bulin
AVAndrey Vasil'ev
Andrey Vasil'ev
ABAndrei Belsky
Andrei Belsky
DADavid Amans
David Amans
GLGilles Ledoux
Gilles Ledoux
CDChristophe Dujardin
Christophe Dujardin
To evaluate the efficiency of the photodynamic effect induced by X-rays, we quantified the fraction of energy deposited in nanoscintillators after interactions with X or γ-rays, introducing ηnano as a new loss parameter.


1 November 2019 in Biomaterials
Verified
Journal Article
Closed access
Mans BroekgaardenMans Broekgaarden
Mans Broekgaarden
SASriram Anbil
Sriram Anbil
Anne-Laure BulinAnne-Laure Bulin
Anne-Laure Bulin
GOGirgis Obaid
Girgis Obaid
ZMZhiming Mai
Zhiming Mai
THTayyaba Hasan
Tayyaba Hasan